Sanjay Vora, MD
Internal Medicine · Marion, OHNPI 1801827977
Payments from drug & device makers
Across 410 payments — averaging $2813.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$895K
- Gilead$88K
- Novartis$64K
- Mylan Specialty L.p.$50K
- Sanofi US Services Inc.$35K
- AstraZeneca$10K
- plus $12K from 31 others
Across 17 payments — averaging $76.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 43 | $894,675 |
| Gilead | 27 | $87,996 |
| Novartis | 14 | $63,875 |
| Mylan Specialty L.p. | 10 | $49,528 |
| Sanofi US Services Inc. | 3 | $34,759 |
| AstraZeneca | 27 | $10,444 |
| Ionis Pharmaceuticals, Inc. | 5 | $5,082 |
| Teva Pharmaceuticals USA, Inc. | 38 | $4,278 |
| GSK | 63 | $556 |
| Novo Nordisk | 19 | $248 |
| AbbVie(2 entities) | 14 | $230 |
| Merck | 28 | $227 |
| Johnson & Johnson | 16 | $210 |
| Lilly USA, LLC | 18 | $195 |
| Pfizer | 20 | $189 |
| Amarin Pharma, Inc. | 9 | $140 |
| Boehringer Ingelheim | 7 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $84 |
| Sanofi-aventis U.S. LLC | 5 | $71 |
| Kowa Pharmaceuticals America, Inc. | 5 | $69 |
| Astellas Pharma US Inc | 4 | $64 |
| Mallinckrodt Hospital Products Inc. | 2 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $51 |
| Vifor Pharma, Inc. | 2 | $42 |
| Strongbridge US Inc. | 3 | $37 |
| E.r. Squibb & Sons, L.L.C. | 3 | $36 |
| Arbor Pharmaceuticals, Inc. | 2 | $32 |
| Upsher-smith Laboratories LLC | 2 | $29 |
| Biohaven Pharmaceuticals, Inc. | 2 | $26 |
| Bayer | 1 | $17 |
| Medtronic | 1 | $16 |
| Advanced Respiratory, Inc | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Grifols USA, LLC | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $11 |
| Xeris Pharmaceuticals, Inc. | 1 | $11 |
| Travere Therapeutics, Inc. | 1 | $3 |
How this compares
$1,153,424 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Marion
- Parminder SinghMarion$690K
- Craig ThompsonMarion$393K
- Vivek AwastyMarion$383K
- Antoinette PragalosCincinnati$27.8M
- Steven FolkerthBeavercreek$9.1M
- Charles EgerCincinnati$8.7M
- Vadim KoshkinCleveland$6.1M
- Nizar DaboulMaumee$4.7M
- Douglas LoganCincinnati$4.7M
- Seref BornovaliLoveland$4.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.